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Abstract
Background: Osteoarthritis is a widespread condition affecting the elderly where ~70–90% of
over 75 year olds are affected, representing one of the largest cost burdens to healthcare in the
western world. The monosodium iodoacetate (MIA) osteoarthritis model has been well described
in the rat especially in terms of the pathological progression of the disease and more recently pain
behaviour. In this study, we characterise, for the first time, MIA induced osteoarthritis in mice and
compare it with nerve-injured mice (partial sciatic nerve injury), using both behavioural and in vivo
electrophysiological measurements. These approaches uniquely allow the threshold and
suprathreshold measures to many modalities to be quantified and so form a basis for improving and
expanding transgenic studies.
Results: Significant mechanical hypersensitivity was observed in the ipsilateral hindpaw in MIA
injected mice at all observed time points following infrapetellar MIA injection (p < 0.05). The
mechanical hypersensitivity exhibited a partial biphasic temporal pattern, but thermal
hypersensitivity was absent. Electrically-evoked dorsal horn neuronal responses in MIA injected
mice were significantly elevated (p < 0.05) with respect to A- and C-fibre firing, input, pinch and
noxious von Frey (26 and 60 g). No significant changes in A- or C-fibre thresholds were observed.
Nerve-injured mice displayed significant behavioural thermal and mechanical hypersensitivity (p <
0.05) and evoked dorsal horn responses were significantly increased with respect to C-fibre firing,
pinch and wind-up (p < 0.05).
Conclusion: The MIA model of osteoarthritic pain in mice displays behavioural characteristics
similar to those observed in rats. Changes in both behavioural measures and neuronal activity from
the paw, suggest that central changes are involved in this pain state, although a role for peripheral
drives is also likely. Moreover, the behavioural and neuronal measures in these two pain models
showed overlapping alterations in terms of certain neuronal measures and mechanical sensitivity
despite their very different pathologies and a loss of input in neuropathy, suggesting some
commonalities in the central processing of different peripheral pain states. This murine model of
osteoarthritis will allow the exploitation of knock out animals to better understand underlying
mechanisms and identify novel molecular targets.
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Background
Chronic pain, caused by diseases such as arthritis or by
nerve damage, affects millions of people worldwide. Oste-
oarthritis (OA) is a widespread condition affecting the
elderly where ~70–90% of over 75 year olds are affected
[1], and represents one of the largest cost burdens to
healthcare in the western world accounting for 1–2.5% of
their gross national product [2]. The majority of com-
plaints concerning the disease are of chronic pain as well
as a loss of joint function. Although the prevalence of neu-
ropathic pain is difficult to ascertain due to its multifari-
ous pathologies (e.g. postherpetic neuralgia, painful
diabetic peripheral neuropathy, HIV polyneuropathy,
etc.) it also presents a significant burden both to individ-
uals and healthcare systems alike [3].
The majority of OA research has concentrated on the bio-
chemical and anatomical pathology observed during the
progression of the disease rather than studies involving
the ensuing pain. Since there are no current therapies to
slow the disease progression [4], analgesia is the first line
treatment for OA. OA joint pain is described as a chronic
and deep aching poorly localised pain, which is aggra-
vated by physical activity and changes in the weather.
Classical analgesics include paracetamol (acetami-
nophen), nonsteroidal anti-inflammatory drugs
(NSAIDs), opioids and steroids. In the majority of
patients, these treatments do not provide full pain relief
and also display significant side effect profiles Although
more is known with regards to the mechanisms underly-
ing neuropathic pain [5,6], the knowledge is far from
complete. Moreover, opioids, antidepressants and anti-
convulsants (e.g. gabapentin) are used in the treatment of
neuropathic pain but these therapies often display mixed
efficacy in different patient groups. It is therefore impor-
tant to try to elucidate the mechanisms responsible for the
induction and maintenance of these pain states to help in
the development of more effective analgesics for the treat-
ment of OA and neuropathic pain. One such approach is
to use transgenic mice to identify possible novel molecu-
lar targets. Success in these approaches requires robust
and translational models.
The monosodium iodoacetate (MIA) OA model has been
well described in the rat especially in terms of the patho-
logical progression of the disease [7] and more recently
pain behaviour [8,9]. Iodoacetate disrupts glycolysis by
inhibition of glyceraldehyde-3-phosphate dehydroge-
nase, and subsequently causes chondrocyte death in vitro
and in vivo [10]. This, therefore, represents an effective
model of OA since it is thought that an imbalance occurs
between the synthetic and degradative pathways within
the articular cartilage resulting in abnormal cellular
metabolism and that this represents a major causative fac-
tor of OA [11,12]. Since the structural integrity of cartilage
relies on the normal functioning of chondrocytes, intra-
articular injection with MIA produces cartilage degenera-
tion and perturbations of the subchondral bone consist-
ent with the clinical histopathology of OA [12-14]. As this
degenerative model progresses, the subchondral bone
becomes exposed generating joint impairment and associ-
ated pain [12] and mechanical hypersensitivity [8,9]. The
pain-related behaviour in this model is thought to be
characterised by an early acute inflammatory phase result-
ing from a fluid expansion of the synovial membrane fol-
lowed by a persistent phase where the inflammation is
largely resolved and is not thought to contribute to the
pain pathogenesis [15].
The emphasis of this study concerns the pain associated
with OA rather than the degenerative process per se since
numerous papers have investigated the biochemical and
pathological processes associated with this model [7,16].
Nevertheless, there are no studies that have compared
both the behavioural and neuronal phenotypes of OA and
neuropathy, a key to understanding the relations between
pain mechanisms and symptoms in animals, especially
the mouse where transgenic approaches can be used to
reveal potential target mechanisms.
In this study we characterise, for the first time: MIA
induced OA in C57Bl/6 mice using both behavioural and
in vivo electrophysiological measurements; and compare
the neuronal attributes of dorsal horn neuronal record-
ings in, partial sciatic nerve ligation (PSNL), a model of
neuropathic pain. Whereas behaviour informs on thresh-
old responses in awake animals, in vivo electrophysiology
can quantify suprathreshold responses which can equate
intensities that produce high levels of pain scores in
patients.
Results
The MIA model of osteoarthritis
Animal development, general health, motor coordination and 
behaviour
No differences in body weight gain were observed
between MIA-injected (22.7 ± 1.5 g, day 14) and saline-
injected (21.4 ± 1.6 g, day 14) littermates at any time
point throughout the study. The general health of the ani-
mals was good and no signs of obvious spontaneous pain
behaviour, impaired motor function or distress were
observed.
Motor coordination was assessed using the rotarod (Fig-
ure 1). Pre-injection (baseline) latencies to fall were simi-
lar in the saline (256 ± 6.9 s) and MIA-injected groups
(269 ± 10.2 s; Figure 1). The mean latency to fall slightly
increased over time suggesting that motor learning is
present. A slight temporal biphasic trend, however, was
observed for the MIA-injected mice when compared withMolecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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the saline-injected mice; the mean latency to fall in the
MIA-injected mice was significantly reduced at day 14
(266 ± 13 s) when compared with saline-injected mice
(299 ± 0.5 s, p < 0.05, n = 10) (Figure 1). Although not
quantified, no obvious differences in gait were observed at
any time throughout the study.
Behavioural mechanical hypersensitivity (mechanical
allodynia) following MIA injection was assessed using the
up-down method (Figure 2A). No significant changes
from baseline were observed for contralateral MIA (data
not shown) or ipsilateral saline responses (Figure 2A).
Pre-injection (baseline) withdrawal responses were simi-
lar in the saline (0.90 ± 0.04 g) and MIA-injected groups
(0.90 ± 0.03 g; Figure 2A). Significant mechanical hyper-
sensitivity (i.e. a reduction in the force required to elicit a
paw withdrawal) was observed in the ipsilateral hindpaw
in MIA-injected animals at all observed time points fol-
lowing MIA injection (Figure 2A). MIA-injected mice dis-
played significantly decreased ipsilateral paw withdrawal
thresholds when compared to ipsilateral saline (p < 0.001,
n = 16) and contralateral MIA response thresholds (p <
0.01, n = 18) (Figure 2A). Mechanical hypersensitivity in
the MIA-injected group displayed a slight temporal bipha-
sic profile. The first phase of reduced withdrawal thresh-
olds declined to a minimum at day 4 (0.34 ± 0.03 g) and
7 (0.32 ± 0.05 g), followed by a slight increase at day 11.
Following this, withdrawal thresholds declined for a sec-
ond time and persisted even when the study was extended
to 28 days.
Behavioural thermal (heat) hypersensitivity (thermal
hyperalgesia) following MIA injection was assessed using
the Hargreaves' apparatus (Figure 2B). Pre-injection paw
withdrawal latencies to a noxious stimulus were similar in
both saline- (8.0 ± 0.8 s) and MIA-injected mice (7.7 ± 0.6
s) (Figure 2B). MIA-injected mice did not exhibit thermal
hypersensitivity since the latency of hindpaw withdrawals
to a noxious stimulus was not different from either pre-
injection times nor latencies in saline injected animals
(Figure 2B).
Spinal cord electrophysiology of dorsal horn neurones following MIA 
injection
Recordings were made from ipsilateral wide dynamic
range dorsal horn neurones in MIA- (n = 12) and saline-
injected mice (n = 13). No significant differences were
observed for the mean depth of the neuronal recordings
in the MIA- (517 ± 48 μm) and saline-injected neurones
(508 ± 50 μm) thus allowing direct comparisons of the
neuronal responses between the two groups. All of the
cells had peripheral receptive fields on the plantar aspect
of the hindpaw, where the most responsive areas were typ-
ically located in the toes. Electrophysiology experiments
were performed between days 14–21 (post-injection),
when the behavioural phenotype was persistent.
In the animals that received intra-articular injection of
MIA, the responses to a train of 16 stimuli at 3 times C-
fibre threshold, was found to have induced a significant
facilitatory effect on A- and C-fibre-evoked responses and
input (p < 0.05) but had no effect on A- or C-fibre thresh-
olds (Table 1). Although not significant, a general facilita-
tory trend was observed for post-discharge and wind-up
measures (Table 1). Wind-up, where dorsal horn neu-
rones become hyperexcitable following repetitive C-fibre
stimulation, was observed for all neurones in both
groups. On comparing the rates of wind-up (i.e. Δ action
potentials/stimulus no), Hill slopes for MIA-injected mice
were significantly elevated compared to saline control ani-
mals (Table 1, p < 0.05).
Dorsal horn neuronal responses were also recorded in
response to a wide range of natural stimuli. Neuronal
responses to brush, non-noxious cooling (acetone), nox-
ious cold (1°C water jet) were similar in the two groups
(Table 1). Neuronal responses to noxious pinch, however,
were facilitated in MIA-injected mice compared with
saline controls (Table 1, p < 0.05).
Spinal neuronal responses were then recorded in response
to graded suprathreshold mechanical (1 – 60 g) and ther-
mal stimuli (30 – 40°C water jet) (Figure 3A &3B). MIA-
injected mice displayed enhanced evoked responses to
punctate mechanical and thermal stimuli in an intensity-
dependent manner. Although statistically significant
effects were observed only for mechanical stimuli in the
Motor coordination of MIA-injected mice Figure 1
Motor coordination of MIA-injected mice. Latency to 
fall from the rotarod is expressed as mean ± S.E.M. Baseline 
(BL) measurements were measured 2–4 days before injec-
tion and expressed as a single mean value. * p < 0.05 com-
pared with saline control animals (n = 10).Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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noxious range (von Frey 26 g and 60 g, p < 0.05), a trend
for facilitation in response to thermal (heat) stimuli (Fig-
ure 3B) was also evident.
The partial sciatic nerve ligation (PSNL) model of 
neuropathic pain
Animal nociceptive behaviour
Mechanical hypersensitivity was assessed, as before, using
the up-down paradigm (Figure 4A). No significant
changes from baseline were observed for contralateral
PSNL (data not shown) or ipsilateral sham responses (Fig-
ure 4A). Pre-surgery (baseline) withdrawal responses were
similar in the sham (0.79 ± 0.03 g) and PSNL groups (0.74
± 0.05 g). Significant mechanical hypersensitivity (i.e.
behavioural mechanical allodynia) was observed in the
ipsilateral hindpaw in PSNL animals at all observed time
points following surgery (Figure 4A). Neuropathic mice
displayed significantly decreased ipsilateral paw with-
drawal thresholds to a punctate mechanical stimulus
when compared to ipsilateral sham (p < 0.001, n = 11)
and contralateral PSNL response thresholds (p < 0.001, n
= 11) (Figure 4A), consistent with data reported from
other groups.
Behavioural thermal hypersensitivity (thermal hyperalge-
sia) following PSNL surgery was assessed using the Har-
greaves' apparatus (Figure 4B). Pre-surgery paw
withdrawal latencies to a noxious stimulus were similar in
both sham (8.9 ± 1.2 s) and PSNL mice (8.2 ± 0.6 s) (Fig-
ure 4B). No significant changes from baseline were
observed for contralateral PSNL (data not shown) or ipsi-
lateral sham responses (Figure 4B). Significant heat hyper-
sensitivity was observed in the ipsilateral hindpaw in
PSNL animals following surgery (Figure 4B). Neuropathic
mice displayed significantly decreased ipsilateral paw
withdrawal thresholds to a thermal stimulus when com-
pared to ipsilateral sham (p < 0.001, n = 11) and contral-
ateral PSNL response thresholds (p < 0.01, n = 11) (Figure
4A), consistent with other published data.
Spinal cord electrophysiology of dorsal horn neurones following PSNL 
surgery
Recordings were made from wide dynamic range ipsilat-
eral dorsal horn neurones in PSNL (n = 13) and sham
mice (n = 12). No significant differences were observed
for the mean depth of the neuronal recordings in the
PSNL (548 ± 23 μm) and sham mice neurones (543 ± 55
μm) thus allowing direct comparisons of the neuronal
responses between the two groups. Depths and control
responses of neurones in the PSNL animals were very sim-
ilar to the comparable MIA groups. All of the cells had
peripheral receptive fields on the plantar aspect of the
hindpaw, where the most responsive areas were typically
located in the toes. Electrophysiology experiments were
performed between days 14–21 (post-surgery), when the
behavioural phenotype was persistent.
In response to a train of 16 stimuli at 3 times C-fibre
threshold, PSNL surgery was found to have a significant
effect on C-fibre-evoked responses (p < 0.05), but no sig-
nificant effects on any other electrical measure (Table 2).
Similar to MIA, wind-up was observed in both neurones
in PSNL and sham mice. Comparisons of Hill slopes
revealed that PSNL surgery had a significant effect on the
wind-up of dorsal horn neurones (p < 0.05; Table 2).
Behavioural nociception in MIA-injected mice Figure 2
Behavioural nociception in MIA-injected mice. A. 
Development of mechanical hypersensitivity in MIA-injected 
mice. Graph depicts the changes in mechanical force 
required to elicit a paw withdrawal in response to a mechan-
ical stimulus for the ipsilateral and contralateral hindpaws of 
MIA-injected mice (n = 18; day 28 n = 4) and the ipsilateral 
hindpaws of saline-injected mice (n = 16; day 28 n = 4). 50% 
paw withdrawal thresholds (PWT) are expressed as mean ± 
S.E.M. * denotes significant differences of ipsilateral MIA v 
ipsilateral saline; denotes significant differences of MIA ipsilat-
eral v MIA contralateral. 3 symbols, p < 0.001; 2 symbols, p < 
0.01; 1 symbol, p < 0.05. 2B. Lack of development of thermal 
hypersensitivity in MIA-injected mice. Graph depicts the time 
taken to elicit paw withdrawal in response to a noxious ther-
mal stimulus for the ipsilateral and contralateral hindpaws of 
MIA-injected mice (n = 11) and the ipsilateral hindpaws of 
saline-injected mice (n = 11).Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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Dorsal horn neuronal responses were also recorded in
response to a wide range of natural stimuli. Neuronal
responses to brush, non-noxious cooling (acetone), nox-
ious cold (1°C water jet) were similar in the two groups
(Table 2). Neuronal responses to noxious pinch, however,
were facilitated in PSNL mice compared with sham con-
trols (Table 1, p < 0.05).
Spinal neuronal responses were then recorded in response
to graded suprathreshold mechanical (1 – 60 g) and ther-
mal stimuli (30 – 40°C water jet) (Figure 5). Although
neither mechanical nor thermal responses were signifi-
cantly different from sham, a trend for facilitation in
response to both mechanical (Figure 5A) and thermal
(heat) stimuli (Figure 5B) was evident.
Increased stimulus-independent neuronal firing has been
widely reported for neuropathic models in rats [17].
Although mean frequencies of stimulus-independent fir-
ing were increased, this was not significant (1.4 ± 2.4 Hz
in sham and 3.4 ± 1.3 Hz in PSNL); 38% of neurones were
spontaneously active in the PSNL group compared with
28% of those recorded from the sham group.
Discussion
At present, the clinical treatment of OA is at best only par-
tially effective and with the elderly population increasing,
the prevalence of OA pain will rise requiring a greater
need for clinically effective drugs to treat the pain associ-
ated with this disease. This highlights the need for effec-
tive models of OA pain in order to study OA pain
pathogenesis and to identify novel therapeutic targets. The
same holds for neuropathic pain. Here we report clear
changes in behavioural and neuronal responses in the
MIA model.
This study provides the first characterisation of MIA-
induced OA in mice in terms of both pain behaviour and
subsequent neuronal characterisation. The behavioural
results, in this study, clearly demonstrate that a single
infrapatellar injection of MIA into mice results in an early
incidence of mechanical hypersensitivity on the hindpaw
that is maintained throughout the testing period (28
days). The prevalence of behavioural mechanical hyper-
sensitivity and absence of thermal hypersensitivity is con-
sistent with the findings of other studies conducted in rats
[9,16,18-20] and correlates well with clinical observations
where, in some cases, patients report improvements in
pain scores after application of heat or cooling packs. In
rheumatoid arthritis in mice, induced using CFA, behav-
ioural hypersensitivities are observed both for mechanical
and thermal stimuli [21], thus highlighting the differences
between these two disorders. Generally, OA has been
regarded primarily as a noninflammatory arthropathy,
however, local inflammation and synovitis are clinically
reported and have been observed in animal models of OA.
In this study, OA behaviour developed with a slight tem-
poral biphasic profile. Although this early phase may rep-
resent the early synovial inflammation (synovitis), which
contributes to the early development of OA [22]; it might
be that the MIA itself is having a direct pro-inflammatory
effect. Similar, but more marked, temporal patterns of OA
behaviour have been observed following MIA injection in
rats, where the first phase peaked at day 4 and was largely
resolved by day 7, the second phase was initiated at day 14
and remained unresolved for the study duration
[9,15,18,19]. In this study, therefore, the neuronal charac-
terisation was performed from day 14, when the inflam-
mation is thought to have been largely resolved and a
more persistent pain state exists, since NSAIDs have previ-
ously only been found to be effective in the 3 days follow-
ing MIA injection [8].
Although von Frey filaments were applied to the plantar
aspect of the hind paw rather than the skin overlying the
knee joint due to experimental hindrances; referred pain
in the thigh, leg and foot of OA patients has been reported
[23,24]. Cell bodies of afferents from the knee are thought
to co-localise in DRGs with those of the hindpaw since
retrograde labelling studies have shown that L3-L5 pre-
dominantly receive primary afferent input from the knee
[25] and L3, L4 and L5 DRGs receive hind paw afferents
[26]. This juxtaposition permits crosstalk such that pain
transmitted by the afferents supplying the knee would
engender pain in the hind paw. The behavioural studies of
evoked pain in the hind paw support secondary hyperal-
gesia as this is characterised by mechanical hypersensitiv-
ity and often lacks heat hypersensitivity [27]. The spinal
Table 1: A comparison of dorsal horn neuronal responses evoked 
using electrical and natural stimuli in MIA and saline-injected 
mice
MIA-injected Saline-injected
A-fibre threshold (mA) 0.26 ± 0.05 0.25 ± 0.08
C-fibre threshold (mA) 1.07 ± 0.29 1.5 ± 0.25
A-fibre response (AP) 106 ± 15* 68 ± 10
C-fibre response (AP) 190 ± 35* 109 ± 13
Post discharge (AP) 215 ± 40 135 ± 20
Input (AP) 203 ± 34* 110 ± 22
Wind-up (AP) 257 ± 81 163 ± 37
Hill slope 24.3 ± 3.1* 17.2 ± 1.9
Brush (AP) 28 ± 7 36 ± 15
Pinch (AP) 145 ± 20* 86 ± 15
Acetone (AP) 14 ± 6 10 ± 5
1°C 19 ± 7 16 ± 5
Data are presented as mean ± S.E.M. for dorsal horn neurones 
recorded in MIA- (n = 12) and saline-injected mice (n = 13). AP 
represents the mean number of action potentials in response to 
either a peripheral electrical or 10 s natural stimulus. * p < 0.05.Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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cord neuronal recordings bear out this premise in that
measures of central hypersensitivity were observed.
Although cartilage itself is considered aneural, bone is
densely innervated with Aδ and C fibres especially in
regions of maximum load and high turnover such as those
of the proximal and distal head of the femur [28]. During
arthritis, pro-inflammatory agents such as bradykinin,
substance P, and prostaglandins are released into the joint
[29] which can lead to afferent fibre sensitisation and
reductions in fibre thresholds (peripheral sensitisation).
The establishment of OA in this study was accompanied
by increases in electrically evoked A- and C-fibre
responses with no changes in their activation thresholds.
This might also be explained by the activation of silent
nociceptors, which do not normally respond to stimuli
but become active in response to tissue damage/inflam-
mation [30]. These increases in A- and C-fibre firing may
underlie OA patients' accounts of aching and throbbing
pain interspersed with activity related sharp/stabbing pain
[31]. The very clear increase in the non-potentiated 'input'
response, indicative of increased peripheral drives, would
result in an increased nociceptive drive onto dorsal horn
neurons thus facilitating central mechanisms of hypersen-
sitivity such as wind-up. The application of suprathresh-
old stimuli, during the electrophysiological
characterisation, evoked enhanced responses to noxious
mechanical stimuli. This electrophysiology is similar to a
study on CFA-induced arthritis in the rat, where facilitated
mechanical responses in the noxious range and increases
in the proportion of neurones responding to mechanical
stimulation were observed in neurones receiving input for
the joints [32]. Thus the increased input, wind-up, A- and
C-fibre firing, response to pinch and mechanical hyper-
sensitivity observed both in the behaviour and electro-
physiology imply a role for central sensitisation in the
MIA model of OA pain.
Although, peripheral neuropathic trauma may induce the
release of inflammatory mediators this is only likely in the
early stage of neuropathic pain. Likewise, osteoarthritic
degeneration could lead to nerve compression, a common
cause of neuropathic pain but again, this is not likely to be
a major mechanism. It is likely that OA initiates an
inflammatory state as cartilage degrades and then moves
to a nociceptive pain in the later stages with direct physi-
cal stress on bones providing the peripheral drive. Neuro-
pathic pain, by contrast, involves disordered and altered
ion channel and other functions in the damaged and
spared peripheral nerves and is so restricted to the nerve
territory and involves both loss and gain of function. Both
the behavioural and neuronal measures in these models
show overlapping alterations produced by the very differ-
ent pathologies. This suggests some commonalities in the
central processing of different peripheral pain states but
with marked upregulations in the neuropathy model, pos-
sibly compensating for the afferent fibre loss [33].
Mechanical hypersensitivity was marked in both models
but greater in PSNL, perhaps relating to the segmental
changes in the nerve injured zone, where testing was
done. In the MIA model the enhanced mechanical
responses are likely to represent referred pain since the
hindpaws were tested after knee MIA. Both groups
showed larger mechanical evoked responses than their
controls, significant in the MIA group. Input was
enhanced in the MIA group but unchanged after nerve
injury, perhaps reflecting the loss of input caused by the
neuropathy yet enhanced primary drives onto deep dorsal
horn neurones after MIA. The trend towards an increased
Mechanical but not thermal coding of spinal neurones is facil- itated in MIA-injected animals Figure 3
Mechanical but not thermal coding of spinal neu-
rones is facilitated in MIA-injected animals. Stimuli 
were applied to the hindpaw for 10 s and responses are pre-
sented as mean ± S.E.M. (MIA, n = 12; saline, n = 13) A. Dor-
sal horn neurones displayed responses to mechanical stimuli 
in an intensity dependent manner. MIA-injected mice dis-
played exaggerated responses to noxious punctate mechani-
cal stimuli * p < 0.05. B. Dorsal horn neurones displayed 
responses to thermal stimuli in an intensity dependent man-
ner.Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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thermal responses of neurones was not reflected in the
behaviour and this is likely a result of the suprathreshold
nature of the neuronal responses – the responses of the
neurones to lower temperatures, akin to the behaviour
were not altered.
Clinical observations have also suggested central changes
in nociceptive information processing in patients with
OA. Support for this comes from a study conducted in
patients with bilateral symptomatic OA of the knee, where
a single intra-articular injection of bupivacaine (local
anaesthetic) into the most painful knee caused a reduc-
tion in pain scores for both the ipsilateral and contralat-
eral knee [34]. In this study, it seems likely that there is an
important central involvement in OA pain as typical indi-
cators for peripheral sensitisation, namely decreased acti-
vation thresholds for A- and C-fibres (where stimuli
would bypass sensitized peripheral terminals), were not
observed in the neuronal characterisation, although an
increase in input was observed that could reflect aug-
mented excitability. A role for peripheral sensitisation or
altered peripheral drives cannot, therefore, be ruled out
and may be more important during OA pain induction
rather than its maintenance.
At early stages of this model in rats, NSAIDs display good
efficacy but become ineffective at later time points
[8,15,18], and pain behaviour can only be attenuated
using morphine [18] and Gabapentin [16]. Furthermore,
repeat dosing studies, a regimen more consistent with the
clinical setting, found that both gabapentin, used for neu-
ropathic pain in patients, and morphine displayed effi-
cacy in this model [9]. This pharmacology suggests that
the early stages of the model/disease reflect acute inflam-
matory pain, but as the disease progresses the inflamma-
tion is largely resolved and starts to share similarities with
those of neuropathic pain. Furthermore, in one study, a
significant increase in the levels of ATF-3 (a marker for
neuropathy) in L5 dorsal root ganglia was found at days 8
and 14 following MIA injection in rats, however, no dif-
ferences were found at later time points up to days 35
[16].
We demonstrate increases in C-fibre evoked responses
and wind-up of WDR neurones in PSNL mice. Along with
the slight increase in the proportion of neurones display-
ing spontaneous activity (and at a slightly higher rate),
these changes are consistent with those expected for cen-
tral hyperexcitability. Similarly, a trend was observed for
thermally and mechanically evoked responses, although
this did not achieve significance. This is consistent with
electrophysiological studies performed in spinal nerve
ligated rats, where L5 and L6 dorsal roots are tightly
ligated reducing spinal afferent input to the hindpaw to
30–40% [35], but comparable responses are observed in
the sham groups to peripherally applied stimuli [36-38].
This suggests, in concordance with the rat, that these
remaining hyperexcitable neurones can compensate for
the sensory loss occurring in these pain states. Following
nerve injury, α2δ subunits of voltage gated calcium chan-
nels are slowly upregulated in the central terminals of
peripheral nerves leading to spinal hyperexcitability [39],
spinal neurones receive greater descending facilitatory
influences [36] and receptive fields expand [40]. The
former changes are permissive for the actions of gabapen-
tin and pregabalin [41] and may therefore also reflect
both the spinal hyperexcitability observed in OA in this
Behavioural nociception in PSNL mice Figure 4
Behavioural nociception in PSNL mice. A. Develop-
ment of mechanical hypersensitivity in PSNL mice. Graph 
depicts the changes in mechanical force required to elicit a 
paw withdrawal in response to a mechanical stimulus for the 
ipsilateral and contralateral hindpaws of PSNL mice (n = 11) 
and the ipsilateral hindpaws of sham mice (n = 11). 50% paw 
withdrawal thresholds (PWT) are expressed as mean ± 
S.E.M. B. Development of thermal hypersensitivity in PSNL 
mice. Graph depicts the time taken to elicit paw withdrawal 
in response to a noxious thermal stimulus for the ipsilateral 
and contralateral hindpaws of PSNL mice (n = 11) and the 
ipsilateral hindpaws of sham mice (n = 11). * denotes signifi-
cant differences of ipsilateral PSNL v ipsilateral sham; denotes 
significant differences of PSNL ipsilateral v PSNL contralat-
eral. 3 symbols, p < 0.001; 2 symbols, p < 0.01; 1 symbol, p < 
0.05.Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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study and the efficacy of gabapentin observed in rat stud-
ies of OA [9]. Studies of this nature in the MIA model will
allow further comparative mechanistic studies across dif-
ferent pain aetiologies.
Conclusion
Increasing evidence suggests that OA is not a single dis-
ease entity, rather that it is a syndrome arising from a
group of disorders with similar pathologies. It is, there-
fore, naïve to believe that OA pain can be simply classified
and thus it can be described both by inflammatory and
neuropathic pain characteristics. Furthermore, the degen-
erative changes associated with OA might lead to com-
pression of the nerves and may result in peripheral
neuropathy. However, OA pain differs to that of neuro-
pathic pain as in the majority of OA patients, hyperalgesia
is abrogated once the affected joint has been replaced
[27], whereas neuropathic pain is thought to outlast its
primary cause. The central hypersensitivity in OA is likely
to be at least part mediated by chronic nociceptive pain
which is thought reversible following the removal of the
peripheral nociceptive drive.
From this study and others, it would seem that OA pain
represents a distinct pain entity characterised by both
early inflammatory and late persistent pain. Although
neuropathic pain and OA pain are likely to be mediated
by divergent peripheral mechanisms, this study suggests
that they share some common central mechanisms. It
would be interesting, therefore, to investigate the role of
descending facilitation and α2δ subunits in OA pain, two
key modulatory mechanisms of neuropathic pain
[33,38,42]. These results suggest that central sensitisation
underlies the behavioural mechanical hypersensitivity
observed in this model of OA. This murine MIA model of
OA-induced pain, therefore, represents a rapid and relia-
ble tool for identifying novel therapeutic targets especially
when there are no available pharmacological ligands.
Methods
All procedures were performed according to current UK
home office legislature (Animals Scientific procedures
Act, 1986). Adult (8–12 weeks; 20–30 g) C57Bl/6 mice of
mixed gender were used for these studies (Harlan, UK).
Animals were housed in groups of 3–4, with 12 h light/
dark cycle and allowed food and water ad libitum except
during procedural testing. Surgical procedures were per-
formed under general anaesthesia with halothane (1–2%)
delivered in O2.
Monosodium iodoacetate (MIA) injection
OA was induced, in briefly anaesthetised mice, by a single
intra-articular injection of MIA (Sigma, UK) into the knee.
Knee joints were shaved and flexed at a 90° angle; 5 μl of
5 mg/ml MIA in sterile saline (0.9%) was injected through
the infra-patellar ligament into the joint space of the left
(ipsilateral) knee using a 30-gauge 0.5" needle. This con-
centration of MIA has been found previously, in mice, to
precipitate histological changes in the cartilage, consistent
with those of osteoarthritis [43]. Control mice received an
intra-articular injection of vehicle (5 μl sterile saline,
0.9%).
Partial Sciatic Nerve Ligation (PSNL)
Nerve injury was induced in deeply anaesthetised mice
using a method based on that previously described by
[44,45]. The left (ipsilateral) sciatic nerve was exposed
above its trifurcation and one third to one half of the
nerve was tightly ligated using 7-0 non-absorbable silk
suture (Mersilk, Ethicon). The wound was closed in layers
using 4-0 suture (Mersilk, Ethicon), and animals were
allowed to recover. In sham mice, the sciatic nerve was
exposed, but not ligated and was closed as before.
Nociceptive behaviours
All behavioural testing was preceded by two baseline
measurements taken 2–4 days prior to injection/surgery.
A single observer was used for the study, and was blind to
the treatment given to each animal.
Behavioural tactile hypersensitivity (von Frey hairs)
Animals were placed in a Perspex chamber with a wire
mesh floor, and allowed to acclimatise for at least 2 hours
prior to testing. Tactile hypersensitivity was tested by
touching the plantar surface of the hindpaw with von Frey
filaments using the "up-down method" [46], starting with
0.6 g then ranging from 0.07 g to 1.4 g. Positive withdraw-
als were counted as biting, licking and withdrawal during
or immediately following the 3 s stimulus. The strength of
Table 2: A comparison of dorsal horn neuronal responses evoked 
using electrical and natural stimuli in PSNL and sham mice
PSNL Sham
A-fibre threshold (mA) 0.31 ± 0.07 0.27 ± 0.04
C-fibre threshold (mA) 0.77 ± 0.15 1.1 ± 0.21
A-fibre response (AP) 100 ± 11 89 ± 11
C-fibre response (AP) 166 ± 24* 101 ± 10
Post discharge (AP) 144 ± 30 99 ± 15
Input (AP) 211 ± 38 165 ± 29
Wind-up (AP) 104 ± 18 63 ± 12
Hill slope 24.8 ± 4.4* 15.1 ± 1.5
Brush (AP) 94 ± 21 67 ± 17
Pinch (AP) 237 ± 46** 80 ± 10
Acetone (AP) 18 ± 7 9 ± 3
1°C 77 ± 33 31 ± 15
Spontaneous (Hz) 3.4 ± 1.3 1.3 ± 0.8
Data are presented as mean ± S.E.M. for dorsal horn neurones 
recorded in PSNL (n = 13) and sham mice (n = 12). AP represents the 
mean number of action potentials in response to either a peripheral 
electrical or 10 s natural stimulus. * p < 0.05; ** p < 0.01.Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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the von Frey filament was increased or decreased follow-
ing a negative or positive response respectively. This up-
down procedure was applied 4 times following the first
change in response and stimuli were not re-applied within
a 5 minute period. Data are presented as 50% paw with-
drawal threshold (PWT) for each group ± SEM.
Heat hypersensitivity (Hargreaves'test)
Mice were assessed for thermal hypersensitivity as
described by [47]. Mice were placed in translucent cham-
bers and were allowed to acclimatise for at least 1 hour.
Noxious heat sensitivity was measured using a radiant
heat device directed at the plantar aspect of the paw. Paw
withdrawal latencies, accurate to the 0.1 s were noted,
where a maximal cut off time of 20 s was used to minimise
paw damage. The stimulus intensity was adjusted to ~8 s
withdrawal latency for naive animals. Measurements were
taken 3–5 times with at least 5 minutes between tests.
Data are presented as mean withdrawal latency for each
group ± SEM.
Rotarod
Animals (n = 10 per group) were placed on the rotarod at
a speed of 4–40 rpm for a maximum of 300 s. During
baseline tests two training trials were given followed by
two recorded trials. Two sets of baseline values were
recorded and their mean was taken. Animals were
excluded from further testing if they had not achieved a
trial of > 250 s in any of their 8 baseline trials. After sur-
gery, three trials were performed and the mean latency
was recorded. Animals were allowed to rest for at least 15
min between testing. Data are represented as mean
latency to fall for each group ± SEM, where the latency to
fall for mice freely rotating on the drum was recorded fol-
lowing two successive rotations.
Spinal cord electrophysiology
In vivo electrophysiology was performed at days 14–21
following MIA/sham injection or surgery using parylene
coated tungsten electrodes (A-M Systems, USA). Animals
were anaesthetised using urethane (240 mg/Kg), and a
laminectomy was performed exposing L3-L5 of the spinal
cord. Once a single wide dynamic range neurone had
been isolated in the ipsilateral dorsal horn receiving
inputs from the hindpaw, A- and C-fibre thresholds were
measured and noted. A train of 16 electrical stimuli (2 ms
wide pulses, 0.5 Hz), delivered transcutaneously by
means of pins inserted in to the hindpaw, was applied at
3 times the activation threshold for C-fibre responses. A
post stimulus time histogram was constructed and fibre
responses were separated according to latency: A (0–50
ms) C (50–250 ms). Responses occurring after the C fibre
latency band were characterised as post discharge (250–
800 ms). Input (non-potentiated response) was calcu-
lated as the number of action potentials in response to the
first stimulus × total number of stimuli (16). Wind up, a
measure of the neuronal activity in response to a succes-
sion of stimuli and hence synaptic strength, was calcu-
lated as the total number of action potentials evoked at
the end of the train – the input. A wide range of natural
stimuli including brush, von Frey filaments and heat were
applied to the hindpaw for a period of 10 seconds. Data
were captured and analysed using a CED 1401 interface
coupled to a Pentium computer running Spike 2 software
(Cambridge Electronic Design).
Data analyses
Data are expressed as mean ± SEM, where n represents the
number of individual experiments performed. Raw data
were analysed using two-way repeated measure ANOVAs,
Kruskal-Wallis, Mann-Whitney and unpaired student T
tests as appropriate where p < 0.05 was considered signif-
icant.
Mechanical and thermal coding of spinal neurones is unaf- fected in PSNL mice Figure 5
Mechanical and thermal coding of spinal neurones is 
unaffected in PSNL mice. Stimuli were applied to the 
hindpaw for 10 s and responses are presented as mean ± 
S.E.M. (PSNL, n = 13; sham, N = 12). A. Dorsal horn neu-
rones displayed responses to mechanical stimuli in an inten-
sity dependent manner. B. Dorsal horn neurones displayed 
responses to thermal stimuli in an intensity dependent man-
ner.Molecular Pain 2009, 5:18 http://www.molecularpain.com/content/5/1/18
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